4 completed, 1 unknown. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Unknown 1 |
| Phase 1 | 2 | Completed 2 |
Follow Joseph Tuscano: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CC-486, Lenalidomide, and Obinutuzumab for the Treatment of Recurrent or Refractory CD20 Positive B-cell Lymphoma Lenalidomide, Obinutuzumab, Oral Azacitidine - Indolent B-Cell Non-Hodgkin Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma | Phase 1 | Completed | Joseph Tuscano | 8 | 2020-10-23 | 2025-04-24 |
| Ixazomib With Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients With Multiple Myeloma Clarithromycin, Dexamethasone, Ixazomib Citrate - Myeloma | Phase 1 / Phase 2 | Completed | Joseph Tuscano | 32 | 2015-10-22 | 2026-11-02 |
| Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma rituximab, ibritumomab tiuxetan, anti-thymocyte globulin - Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma | Phase 2 | Unknown | Joseph Tuscano | 20 | 2013-03-12 | 2022-11-30 |
| Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma Ofatumumab + Fresh Frozen Plasma - Chronic Lymphocytic Leukemia | Phase 2 | Completed | Joseph Tuscano | 12 | 2013-01-14 | 2021-05-11 |
| Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia Bortezomib, Doxil - Acute Myelogenous Leukemia | Phase 2 | Completed | Joseph Tuscano | 25 | 2012-12-19 | 2021-02-24 |
Leukemia, Lymphocytic, Chronic, B-Cell (2) · Leukemia, Hairy Cell (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, B-Cell (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Neoplasms, Plasma Cell (1)
Antilymphocyte Serum (1) · Azacitidine (1) · Bortezomib (1) · Calcium Dobesilate (1) · Clarithromycin (1) · Cyclosporine (1) · Dexamethasone (1) · Lenalidomide (1) · Mycophenolic Acid (1) · Peripheral Blood Stem Cell Transplantation (1) · Rituximab (1) · cc-486 (1) · ibritumomab tiuxetan (1) · ixazomib (1) · liposomal doxorubicin (1)
United States (5)
Joseph M Tuscano (1)
P30CA093373 (1)